Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Darden's Quarterly Profit, Revenue Beat Expectations
Darden's Quarterly Profit, Revenue Beat Expectations
FedEx Beats Quarterly Profit Expectations
FedEx Beats Quarterly Profit Expectations
Google Sees 'No Change' in Business With Broadcom
Google Sees 'No Change' in Business With Broadcom
Home Sales Fell Again in August as Homebuyers Grapple With Rising Mortgage Rates and Prices
Sales of previously occupied U.S. homes fell for the third month in a row in August, as higher mortgage rates, rising prices and a dearth of properties on the market shut out many would-be homebuyers.
Stretching Your Dollar: Delta Airlines Raises Thresholds to Earn Elite Status
Stretching Your Dollar: Delta Airlines Raises Thresholds to Earn Elite Status
Stretching Your Dollar: How to Travel on A Budget This Fall
Stretching Your Dollar: How to Travel on A Budget This Fall
Ready4Work: Landing Your Dream Job
Ready4Work: Landing Your Dream Job
Unions and Studios to Meet Again
Unions and Studios to Meet Again
'Game of Thrones' Creator and Other Authors Sue ChatGPT-Maker OpenAI for Copyright Infringement
John Grisham, Jodi Picoult and George R.R. Martin are among 17 authors suing OpenAI for “systematic theft on a mass scale,” the latest in a wave of legal action by writers concerned that artificial intelligence programs are using their copyrighted works without permission.
